Cargando…
Advances in lipid-based nanocarriers for breast cancer metastasis treatment
Breast cancer (BC) is the most common cancer affecting women worldwide, with over 2 million women diagnosed every year, and close to 8 million women currently alive following a diagnosis of BC in the last 5-years. The side effects such as chemodrug toxicity to healthy tissues and drug resistance sev...
Autores principales: | Joun, Ingrid, Nixdorf, Sheri, Deng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433809/ https://www.ncbi.nlm.nih.gov/pubmed/36062261 http://dx.doi.org/10.3389/fmedt.2022.893056 |
Ejemplares similares
-
A Review of the Advancements in the in-vitro Modelling of Acute Ischemic Stroke and Its Treatment
por: Johnson, Sarah, et al.
Publicado: (2022) -
Embracing Mechanobiology in Next Generation Organ-On-A-Chip Models of Bone Metastasis
por: Slay, Ellen E., et al.
Publicado: (2021) -
Brazilian breast cancer patient-reported outcomes: What really matters for these women
por: Silva, Aline Silveira, et al.
Publicado: (2022) -
Quantitative and Qualitative Evaluation of Breast Cancer Prognosis: A Sonographic Elastography Study
por: You, Yue, et al.
Publicado: (2019) -
Bridging the Antimicrobial Activity of Two Lactoferricin Derivatives in E. coli and Lipid-Only Membranes
por: Marx, Lisa, et al.
Publicado: (2021)